Drug-Resistant TB: A Survival Guide for Clinicians, 3rd edition
May 13, 2016
Curry International Tuberculosis Center/UCSF is pleased to announce the fully revised and updated 3rd edition of one of its most popular publications, Drug-Resistant Tuberculosis: A Survival Guide for Clinicians. Co-produced with the California Department of Public Health, Tuberculosis Control Branch (CDPH), the Guide is designed for any clinician who participates in the management of patients with drug-resistant TB.
What’s new in the third edition of the Guide?
- Laboratory, a new chapter presenting information about the laboratory tests used to confirm TB infection and/or disease, including tests available for the more rapid molecular detection of TB and drug resistance
- New data on outcomes of treatment for drug-resistant TB and newer drugs and regimens available
- Updated information about 23 medications used to treat tuberculosis, including 5 new fact sheets not included in the second edition: Bedaquiline, Clarithromycin, Delamanid, Meropenem, and Rifapentine
- Expanded information about diagnosing and treating TB disease and LTBI in children, now devoted to its own chapter
- New sections on “Diabetes Mellitus” and “Solid Organ Transplant” in Chapter 7, Co-Morbidities and Special Situations
- Updated listings of resources in the Appendices